Skip to main content
Top
Published in: Inflammation 3/2013

01-06-2013

Serum Levels of the CC Chemokines CCL2, CCL5, and CCL11 in Food Allergic Children with Different Clinical Manifestations

Authors: Masood Radman, Gholamhossin Hassanshahi, Reza Vazirinejad, Mohammad Kazemi Arababadi, Mojgan Noorozi Karimabad, Hossein Khorramdelazad, Houshang Rafatpanah, Fereshteh Iranmanesh, Elham Hakimizadeh, Zahra Ahmadi

Published in: Inflammation | Issue 3/2013

Login to get access

Abstract

Food allergies (FA) are frequent in 8 % of children under 3 years old and approximately 2 % of adults. Chemokine are involved in various allergies such as FA. The present study was aimed to determine CCL2, CCL5, and CCL11 levels in FA. The study population of this cross-sectional study contained 63 patients suffering from FA and 100 healthy controls. Concentrations of CCL2, CCL5, CCL11, and IgE were measured by enzyme-linked immunosorbent assay (ELISA). Eosinophils were counted using Casy Ι cell counter + analyzer system model SCAREF system GmbH. Differences were considered significant at P < 0.05. Current results showed that FA patients had significantly elevated numbers of circulating periphery eosinophils than the disease-free controls. Serum IgE levels in FA patients were also higher than controls. We also showed that serum levels of CCL2 and CCL11 were significantly enhanced in FA patients compared to control but CCL5 was not detectable. Results of present study revealed that both CCL2 and CCL11 were more elevated in FA children suffering from anaphylaxis and urticaria than bronchial asthma and atopic dermatitis. These results also indicated that more increased levels of CCL2 and CCL11 were observed following consumption of cow’s milk and pistachio nuts. Overall, findings of the present study proposed that serum levels of CCL2 and CCL11 are elevated in FA and these may be considered as useful parameters in diagnosis of disorder. It is also possible to design treatments on the basis of blocking of chemokines expression by application of antibodies against them to overcome allergic complications in patients suffering from FA.
Literature
1.
go back to reference Greener, M. 2000. Dissecting the molecular basis of food allergy. Molecular Medicine Today 6(9): 336.PubMedCrossRef Greener, M. 2000. Dissecting the molecular basis of food allergy. Molecular Medicine Today 6(9): 336.PubMedCrossRef
2.
go back to reference Kim, J.W., et al. 2009. Morin inhibits Fyn kinase in mast cells and IgE-mediated type I hypersensitivity response in vivo. Biochemical Pharmacology 77(9): 1506–1512. Epub 2009 Feb 6.PubMedCrossRef Kim, J.W., et al. 2009. Morin inhibits Fyn kinase in mast cells and IgE-mediated type I hypersensitivity response in vivo. Biochemical Pharmacology 77(9): 1506–1512. Epub 2009 Feb 6.PubMedCrossRef
3.
go back to reference Bischoff, S.C., et al. 1996. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology 28(1): 1–13.PubMedCrossRef Bischoff, S.C., et al. 1996. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology 28(1): 1–13.PubMedCrossRef
4.
go back to reference Bischoff, S.C., and S. Kramer. 2007. Human mast cells, bacteria, and intestinal immunity. Immunology Reviews 217: 329–337.CrossRef Bischoff, S.C., and S. Kramer. 2007. Human mast cells, bacteria, and intestinal immunity. Immunology Reviews 217: 329–337.CrossRef
5.
go back to reference Bischoff, S.C. 2009. Physiological and pathophysiological functions of intestinal mast cells. Seminars in Immunopathology 31(2): 185–205. Epub 2009 Jun 17.PubMedCrossRef Bischoff, S.C. 2009. Physiological and pathophysiological functions of intestinal mast cells. Seminars in Immunopathology 31(2): 185–205. Epub 2009 Jun 17.PubMedCrossRef
6.
7.
go back to reference Piliponsky, A.M., et al. 2003. Non-IgE-dependent activation of human lung- and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor. Blood 101(5): 1898–1904. Epub 2002 Oct 10.PubMedCrossRef Piliponsky, A.M., et al. 2003. Non-IgE-dependent activation of human lung- and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor. Blood 101(5): 1898–1904. Epub 2002 Oct 10.PubMedCrossRef
8.
go back to reference Drazen, J.M., J.P. Arm, and K.F. Austen. 1996. Sorting out the cytokines of asthma. The Journal of Experimental Medicine 183(1): 1–5.PubMedCrossRef Drazen, J.M., J.P. Arm, and K.F. Austen. 1996. Sorting out the cytokines of asthma. The Journal of Experimental Medicine 183(1): 1–5.PubMedCrossRef
9.
go back to reference Broide, D., and P. Sriramarao. 2001. Eosinophil trafficking to sites of allergic inflammation. Immunology Reviews 179: 163–172.CrossRef Broide, D., and P. Sriramarao. 2001. Eosinophil trafficking to sites of allergic inflammation. Immunology Reviews 179: 163–172.CrossRef
10.
go back to reference Aminzadeh, F., et al. 2012. Differential expression of CXC chemokines CXCL10 and CXCL12 in term and pre-term neonates and their mothers. American Journal of Reproductive Immunology 68(4): 338–344.PubMedCrossRef Aminzadeh, F., et al. 2012. Differential expression of CXC chemokines CXCL10 and CXCL12 in term and pre-term neonates and their mothers. American Journal of Reproductive Immunology 68(4): 338–344.PubMedCrossRef
11.
go back to reference Shinkai, A., et al. 1999. A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils. Journal of Immunology 163(3): 1602–1610. Shinkai, A., et al. 1999. A novel human CC chemokine, eotaxin-3, which is expressed in IL-4-stimulated vascular endothelial cells, exhibits potent activity toward eosinophils. Journal of Immunology 163(3): 1602–1610.
12.
go back to reference Ahmadi, Z., M.K. Arababadi, and G. Hassanshahi. 2012. CXCL10 activities, biological structure, and source along with its significant role played in pathophysiology of type I diabetes mellitus. Inflammation. doi:10.1007/s10753-012-9555-1. Ahmadi, Z., M.K. Arababadi, and G. Hassanshahi. 2012. CXCL10 activities, biological structure, and source along with its significant role played in pathophysiology of type I diabetes mellitus. Inflammation. doi:10.​1007/​s10753-012-9555-1.
13.
go back to reference Kitaura, M., et al. 1999. Molecular cloning of a novel human CC chemokine (Eotaxin-3) that is a functional ligand of CC chemokine receptor 3. Journal of Biological Chemistry 274(39): 27975–27980.PubMedCrossRef Kitaura, M., et al. 1999. Molecular cloning of a novel human CC chemokine (Eotaxin-3) that is a functional ligand of CC chemokine receptor 3. Journal of Biological Chemistry 274(39): 27975–27980.PubMedCrossRef
14.
go back to reference Ponath, P.D., et al. 1996. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. Journal of Experimental Medicine 183(6): 2437–2448.PubMedCrossRef Ponath, P.D., et al. 1996. Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils. Journal of Experimental Medicine 183(6): 2437–2448.PubMedCrossRef
15.
go back to reference Uguccioni, M., et al. 1997. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. Journal of Clinical Investigation 100(5): 1137–1143.PubMedCrossRef Uguccioni, M., et al. 1997. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines. Journal of Clinical Investigation 100(5): 1137–1143.PubMedCrossRef
16.
go back to reference Plager, D.A., et al. 2010. Gene transcription changes in asthmatic chronic rhinosinusitis with nasal polyps and comparison to those in atopic dermatitis. PLoS One 5(7): e11450.PubMedCrossRef Plager, D.A., et al. 2010. Gene transcription changes in asthmatic chronic rhinosinusitis with nasal polyps and comparison to those in atopic dermatitis. PLoS One 5(7): e11450.PubMedCrossRef
17.
go back to reference Clark, A.T., and P.W. Ewan. 2004. Food allergy in childhood. Archives of Disease in Childhood 89(2): 197.PubMedCrossRef Clark, A.T., and P.W. Ewan. 2004. Food allergy in childhood. Archives of Disease in Childhood 89(2): 197.PubMedCrossRef
18.
go back to reference Simons, F.E. 2010. World Allergy Organization survey on global availability of essentials for the assessment and management of anaphylaxis by allergy-immunology specialists in health care settings. Annals of Allergy, Asthma & Immunology 104(5): 405–412.CrossRef Simons, F.E. 2010. World Allergy Organization survey on global availability of essentials for the assessment and management of anaphylaxis by allergy-immunology specialists in health care settings. Annals of Allergy, Asthma & Immunology 104(5): 405–412.CrossRef
19.
go back to reference Blazquez, A.B., et al. 2010. A functional role for CCR6 on proallergic T cells in the gastrointestinal tract. Gastroenterology 138(1): 275–284. e1-4. Epub 2009 Sep 23.PubMedCrossRef Blazquez, A.B., et al. 2010. A functional role for CCR6 on proallergic T cells in the gastrointestinal tract. Gastroenterology 138(1): 275–284. e1-4. Epub 2009 Sep 23.PubMedCrossRef
20.
go back to reference Lamkhioued, B., et al. 1997. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. Journal of Immunology 159(9): 4593–4601. Lamkhioued, B., et al. 1997. Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. Journal of Immunology 159(9): 4593–4601.
21.
go back to reference Yamada, H., et al. 2000. Eotaxin in induced sputum of asthmatics: relationship with eosinophils and eosinophil cationic protein in sputum. Allergy 55(4): 392–397.PubMedCrossRef Yamada, H., et al. 2000. Eotaxin in induced sputum of asthmatics: relationship with eosinophils and eosinophil cationic protein in sputum. Allergy 55(4): 392–397.PubMedCrossRef
22.
go back to reference Taha, R.A., et al. 2001. Increased expression of the chemoattractant cytokines eotaxin, monocyte chemotactic protein-4, and interleukin-16 in induced sputum in asthmatic patients. Chest 120(2): 595–601.PubMedCrossRef Taha, R.A., et al. 2001. Increased expression of the chemoattractant cytokines eotaxin, monocyte chemotactic protein-4, and interleukin-16 in induced sputum in asthmatic patients. Chest 120(2): 595–601.PubMedCrossRef
23.
go back to reference Bottcher, M.F., et al. 2000. Chemoattractant factors in breast milk from allergic and nonallergic mothers. Pediatric Research 47(5): 592–597.PubMedCrossRef Bottcher, M.F., et al. 2000. Chemoattractant factors in breast milk from allergic and nonallergic mothers. Pediatric Research 47(5): 592–597.PubMedCrossRef
24.
go back to reference Taha, R.A., et al. 2000. Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitis. Journal of Allergy and Clinical Immunology 105(5): 1002–1007.PubMedCrossRef Taha, R.A., et al. 2000. Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitis. Journal of Allergy and Clinical Immunology 105(5): 1002–1007.PubMedCrossRef
25.
go back to reference Li, H., et al. 2007. Allergen-IgE complexes trigger CD23-dependent CCL20 release from human intestinal epithelial cells. Gastroenterology 133(6): 1905–1915. Epub 2007 Sep 25.PubMedCrossRef Li, H., et al. 2007. Allergen-IgE complexes trigger CD23-dependent CCL20 release from human intestinal epithelial cells. Gastroenterology 133(6): 1905–1915. Epub 2007 Sep 25.PubMedCrossRef
26.
go back to reference Hakimizadeh, E., et al. 2012. Association of -592 region of IL-10 polymorphisms with asthma in south-eastern Iranian patients. Clinical Laboratory 58(3–4): 267–271.PubMed Hakimizadeh, E., et al. 2012. Association of -592 region of IL-10 polymorphisms with asthma in south-eastern Iranian patients. Clinical Laboratory 58(3–4): 267–271.PubMed
27.
go back to reference Berkman, N., et al. 2001. Eotaxin-3 but not eotaxin gene expression is upregulated in asthmatics 24 h after allergen challenge. American Journal of Respiratory Cell and Molecular Biology 24(6): 682–687.PubMedCrossRef Berkman, N., et al. 2001. Eotaxin-3 but not eotaxin gene expression is upregulated in asthmatics 24 h after allergen challenge. American Journal of Respiratory Cell and Molecular Biology 24(6): 682–687.PubMedCrossRef
28.
go back to reference Kagami, S., et al. 2003. Significant elevation of serum levels of eotaxin-3/CCL26, but not of eotaxin-2/CCL24, in patients with atopic dermatitis: serum eotaxin-3/CCL26 levels reflect the disease activity of atopic dermatitis. Clinical and Experimental Immunology 134(2): 309–313.PubMedCrossRef Kagami, S., et al. 2003. Significant elevation of serum levels of eotaxin-3/CCL26, but not of eotaxin-2/CCL24, in patients with atopic dermatitis: serum eotaxin-3/CCL26 levels reflect the disease activity of atopic dermatitis. Clinical and Experimental Immunology 134(2): 309–313.PubMedCrossRef
29.
go back to reference Polzer, K., et al. 2008. Eotaxin-3 is involved in Churg–Strauss syndrome—a serum marker closely correlating with disease activity. Rheumatology (Oxford, England) 47(6): 804–808. Epub 2008 Apr 8.CrossRef Polzer, K., et al. 2008. Eotaxin-3 is involved in Churg–Strauss syndrome—a serum marker closely correlating with disease activity. Rheumatology (Oxford, England) 47(6): 804–808. Epub 2008 Apr 8.CrossRef
30.
go back to reference Fulkerson, P.C., et al. 2006. A central regulatory role for eosinophils and the eotaxin/CCR3 axis in chronic experimental allergic airway inflammation. Proceedings of the National Academy of Sciences of the United States of America 103(44): 16418–16423. Epub 2006 Oct 23.PubMedCrossRef Fulkerson, P.C., et al. 2006. A central regulatory role for eosinophils and the eotaxin/CCR3 axis in chronic experimental allergic airway inflammation. Proceedings of the National Academy of Sciences of the United States of America 103(44): 16418–16423. Epub 2006 Oct 23.PubMedCrossRef
31.
go back to reference Matsuura, H., et al. 2009. Elevation of plasma eotaxin levels in children with food allergy. Nihon Rinshō Men’eki Gakkai Kaishi 32(3): 180–185.PubMedCrossRef Matsuura, H., et al. 2009. Elevation of plasma eotaxin levels in children with food allergy. Nihon Rinshō Men’eki Gakkai Kaishi 32(3): 180–185.PubMedCrossRef
32.
go back to reference Baggiolini, M., and C.A. Dahinden. 1994. CC chemokines in allergic inflammation. Immunology Today 15(3): 127–133.PubMedCrossRef Baggiolini, M., and C.A. Dahinden. 1994. CC chemokines in allergic inflammation. Immunology Today 15(3): 127–133.PubMedCrossRef
33.
go back to reference Lukacs, N.W. 2001. Role of chemokines in the pathogenesis of asthma. Nature Reviews Immunology 1(2): 108–116.PubMedCrossRef Lukacs, N.W. 2001. Role of chemokines in the pathogenesis of asthma. Nature Reviews Immunology 1(2): 108–116.PubMedCrossRef
34.
go back to reference Kaplan, A.P. 2001. Chemokines, chemokine receptors and allergy. International Archives of Allergy and Immunology 124(4): 423–431.PubMedCrossRef Kaplan, A.P. 2001. Chemokines, chemokine receptors and allergy. International Archives of Allergy and Immunology 124(4): 423–431.PubMedCrossRef
Metadata
Title
Serum Levels of the CC Chemokines CCL2, CCL5, and CCL11 in Food Allergic Children with Different Clinical Manifestations
Authors
Masood Radman
Gholamhossin Hassanshahi
Reza Vazirinejad
Mohammad Kazemi Arababadi
Mojgan Noorozi Karimabad
Hossein Khorramdelazad
Houshang Rafatpanah
Fereshteh Iranmanesh
Elham Hakimizadeh
Zahra Ahmadi
Publication date
01-06-2013
Publisher
Springer US
Published in
Inflammation / Issue 3/2013
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-012-9577-8

Other articles of this Issue 3/2013

Inflammation 3/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.